Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
The Journal of Neuropsychiatry and Clinical Neurosciences
|
December 1, 2006
Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder
Matthew J Hoptman, Jan Volavka, Pál Czobor, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 14, 2008
Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia
Jeffrey W Swanson, Marvin S Swartz, Richard A Van Dorn, et al.
Human Psychopharmacology
|
August 9, 2011
Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain
Vincenzo De Luca, Renan P Souza, Emanuela Viggiano, et al.
The Journal of Clinical Psychiatry
|
June 6, 2009
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response
Jean-Pierre Lindenmayer, Hong Liu-Seifert, Pandurang M Kulkarni, et al.
Psychiatry Research
|
October 29, 2005
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder
Matthew J Hoptman, Jan Volavka, Elisabeth M Weiss, et al.
Pharmacological Research
|
February 3, 2005
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatment
Vincenzo De Luca, John B Vincent, Daniel J Müller, et al.
The American Journal of Psychiatry
|
June 4, 2002
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
Robert M Bilder, Robert S Goldman, Jan Volavka, et al.
Neuroscience Letters
|
April 13, 2005
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia
Daniel J Müller, Tim A Klempan, Vincenzo De Luca, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 6, 2005
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia
Daniel J Müller, Vincenzo De Luca, Tricia Sicard, et al.
Journal of Clinical Psychopharmacology
|
July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study
Bruce J Kinon, Jan Volavka, Virginia Stauffer, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
The Journal of Neuropsychiatry and Clinical Neurosciences
|
December 1, 2006
Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder
Matthew J Hoptman, Jan Volavka, Pál Czobor, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 14, 2008
Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia
Jeffrey W Swanson, Marvin S Swartz, Richard A Van Dorn, et al.
Human Psychopharmacology
|
August 9, 2011
Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain
Vincenzo De Luca, Renan P Souza, Emanuela Viggiano, et al.
The Journal of Clinical Psychiatry
|
June 6, 2009
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response
Jean-Pierre Lindenmayer, Hong Liu-Seifert, Pandurang M Kulkarni, et al.
Psychiatry Research
|
October 29, 2005
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder
Matthew J Hoptman, Jan Volavka, Elisabeth M Weiss, et al.
Pharmacological Research
|
February 3, 2005
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatment
Vincenzo De Luca, John B Vincent, Daniel J Müller, et al.
The American Journal of Psychiatry
|
June 4, 2002
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
Robert M Bilder, Robert S Goldman, Jan Volavka, et al.
Neuroscience Letters
|
April 13, 2005
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia
Daniel J Müller, Tim A Klempan, Vincenzo De Luca, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 6, 2005
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia
Daniel J Müller, Vincenzo De Luca, Tricia Sicard, et al.
Journal of Clinical Psychopharmacology
|
July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study
Bruce J Kinon, Jan Volavka, Virginia Stauffer, et al.
Page
of 10